Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by three phases: chronic, accelerated, and blast phase. However; first- and second-generation tyrosine kinase inhibitors are used for the treatment of CML with common and uncommon adverse events. Here, we report a 24-year-...

Descripción completa

Detalles Bibliográficos
Autores principales: Obeidat, Khaldun, Alsaud, Arwa, Ashour, Amr, Azrieh, Bahjat, Abu-Tineh, Mohammad, Mohamed, Shehab Fareed, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036574/
https://www.ncbi.nlm.nih.gov/pubmed/32110208
http://dx.doi.org/10.1159/000504937
Descripción
Sumario:Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by three phases: chronic, accelerated, and blast phase. However; first- and second-generation tyrosine kinase inhibitors are used for the treatment of CML with common and uncommon adverse events. Here, we report a 24-year-old male with CML in chronic phase started on imatinib as upfront medication who developed tremor and recovered spontenously after 3 years.

Ejemplares similares